Advertisement
U.S. markets open in 6 hours 2 minutes

Titan Pharmaceuticals, Inc. (TTNP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
7.33-2.08 (-22.10%)
At close: 04:00PM EDT
7.25 -0.08 (-1.09%)
After hours: 07:21PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 3/19/2024
Current
9/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
5.52M7.12M9.70M12.46M11.46M
Enterprise Value
-1.98M7.14M8.73M9.71M7.22M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/A
Price/Sales (ttm)
105.18125.55164.45185.847.43
Price/Book (mrq)
0.68N/AN/A9.143.31
Enterprise Value/Revenue
-38.00N/A8.73kN/A141.61
Enterprise Value/EBITDA
0.25-3.51-5.63-5.87-2.81

Trading Information

Stock Price History

Beta (5Y Monthly) 1.34
52-Week Change 3-52.40%
S&P500 52-Week Change 328.64%
52 Week High 317.00
52 Week Low 35.00
50-Day Moving Average 36.96
200-Day Moving Average 39.12

Share Statistics

Avg Vol (3 month) 310.5k
Avg Vol (10 day) 310.54k
Shares Outstanding 5753.31k
Implied Shares Outstanding 6753.31k
Float 8399.73k
% Held by Insiders 151.14%
% Held by Institutions 16.44%
Shares Short (Feb 29, 2024) 412.14k
Short Ratio (Feb 29, 2024) 40.9
Short % of Float (Feb 29, 2024) 42.15%
Short % of Shares Outstanding (Feb 29, 2024) 41.61%
Shares Short (prior month Jan 31, 2024) 45.16k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 01, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Jan 09, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sep 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-51,525.00%

Management Effectiveness

Return on Assets (ttm)-61.11%
Return on Equity (ttm)-105.54%

Income Statement

Revenue (ttm)305k
Revenue Per Share (ttm)0.41
Quarterly Revenue Growth (yoy)-95.80%
Gross Profit (ttm)N/A
EBITDA -7.35M
Net Income Avi to Common (ttm)-6.17M
Diluted EPS (ttm)-8.20
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.1M
Total Cash Per Share (mrq)10.78
Total Debt (mrq)597k
Total Debt/Equity (mrq)7.34%
Current Ratio (mrq)5.30
Book Value Per Share (mrq)10.83

Cash Flow Statement

Operating Cash Flow (ttm)-6.42M
Levered Free Cash Flow (ttm)-5.24M